Skip to main navigation Skip to search Skip to main content

Safety and Glycemic Outcomes During the MiniMedTM Advanced Hybrid Closed-Loop System Pivotal Trial in Children and Adolescents with Type 1 Diabetes

  • MiniMedTM AHCL Study Group

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)755-764
Number of pages10
JournalDiabetes Technology and Therapeutics
Volume25
Issue number11
DOIs
StatePublished - Nov 1 2023

ASJC Scopus Subject Areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Medical Laboratory Technology

Keywords

  • A1C
  • Active insulin time
  • Advanced hybrid closed loop
  • Glucose target
  • Pediatric
  • Time-in-range
  • Type 1 diabetes
  • Diabetic Ketoacidosis/etiology
  • Humans
  • Blood Glucose
  • Glycated Hemoglobin
  • Treatment Outcome
  • Glucose
  • Diabetes Mellitus, Type 1/drug therapy
  • Hypoglycemia/chemically induced
  • Adolescent
  • Blood Glucose Self-Monitoring
  • Adult
  • Hypoglycemic Agents/therapeutic use
  • Insulin Infusion Systems
  • Child
  • Insulin/therapeutic use

Cite this